| 1 |
34382511 | SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway. | 2022 |
1 |
| 2 |
33932092 | SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis. | 2021 Nov |
1 |
| 3 |
31593801 | A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. | 2020 Jan 1 |
2 |
| 4 |
33069748 | Restoration of PP2A levels in inflamed microglial cells: Important for neuroprotective M2 microglial viability. | 2020 Dec 15 |
1 |
| 5 |
30917007 | The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction. | 2019 Jun |
2 |
| 6 |
29986744 | Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells. | 2018 Jul 9 |
1 |
| 7 |
28813646 | Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells. | 2017 Nov 15 |
1 |
| 8 |
26967515 | A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia. | 2016 Jul |
2 |
| 9 |
27556014 | The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. | 2016 Dec |
1 |
| 10 |
25637283 | Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. | 2015 Apr |
1 |
| 11 |
25699237 | Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. | 2015 |
1 |
| 12 |
26023836 | Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer. | 2015 May 27 |
4 |
| 13 |
25207757 | Modulation of IL-33/ST2-TIR and TLR signalling pathway by fingolimod and analogues in immune cells. | 2014 Dec |
3 |
| 14 |
22109829 | Reactivating PP2A by FTY720 as a novel therapy for AML with C-KIT tyrosine kinase domain mutation. | 2012 Apr |
3 |
| 15 |
21233840 | PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. | 2011 Apr |
2 |
| 16 |
18213449 | Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias. | 2008 Jun |
1 |
| 17 |
17717597 | FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. | 2007 Sep |
1 |
| 18 |
12711631 | A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. | 2003 Apr |
2 |
| 19 |
11429058 | Coordinate involvement of cell cycle arrest and apoptosis strengthen the effect of FTY720. | 2001 Jun |
1 |